Silicon Laboratories Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 41.6% | 42.3% | 48.2% | 47.3% | 45.7% | 45.7% | 45.0% | 43.9% | 42.2% | 36.6% | 43.3% | 38.4% | 40.1% | |
| 58.4% | 57.7% | 51.8% | 52.7% | 54.3% | 54.3% | 55.0% | 56.1% | 57.8% | 63.4% | 56.7% | 61.6% | 59.9% | |
| 38.8% | 96.0% | 75.8% | 59.1% | 50.0% | 49.6% | 49.6% | 45.5% | 42.6% | 43.0% | 38.7% | 41.6% | 41.5% | |
| 13.6% | 38.7% | 31.5% | 26.6% | 22.1% | 21.9% | 23.4% | 22.4% | 21.2% | 22.0% | 26.0% | 24.7% | 23.5% | |
| 52.4% | 141.9% | 107.4% | 85.7% | 72.1% | 71.5% | 73.1% | 67.9% | 63.8% | 65.0% | 59.4% | 66.3% | 63.7% | |
| 6.0% | -84.2% | -55.6% | -33.0% | -17.9% | -17.2% | -18.1% | -11.9% | -6.0% | -1.6% | -2.8% | -4.7% | -3.8% | |
| 0.7% | 1.1% | 0.5% | 0.2% | 0.2% | 0.2% | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | |
| 6.7% | -98.2% | -53.5% | -31.3% | -15.9% | -15.6% | -16.1% | -10.0% | -4.6% | -0.3% | -6.4% | -3.7% | -3.8% | |
| 1.7% | -17.9% | -0.4% | 25.2% | 1.2% | -1.3% | 1.1% | 1.3% | 0.2% | 1.0% | 1.0% | 0.9% | 0.8% | |
| 5.1% | -80.4% | -53.1% | -56.5% | -17.1% | -14.3% | -17.1% | -11.3% | -4.8% | -1.3% | -7.4% | -4.6% | -4.6% | |
| 13.7% | -65.1% | -41.1% | -22.4% | -8.8% | -8.4% | -9.3% | -4.8% | -0.6% | 3.8% | -2.4% | 3.8% | 1.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.